Bebell, Lisa M
- Massachusetts General Hospital · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #9,198
- R01 Holder
- Early Career
- Mentor
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#9,198
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Bebell, Lisa M as a PI. Multi-PI records show the full award amount for context.
- 1R01HD112302-01R01Contact PIMicrobiome-driven immune changes and growth stunting in HIV-exposed uninfected childrenMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$810.5Kaward amount
- 5K23AI138856-05K23Contact PIHIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in UgandaMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$271.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Bebell, Lisa M as a PI.
FY2023 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardMassachusetts General Hospital
- 2020R01 Grant Holder
- 2021$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2023$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #9198